These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 7064851

  • 1. Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease.
    Gagnon RM, Morissette M, Présant S, Savard D, Lemire J.
    Am J Cardiol; 1982 Apr 01; 49(5):1267-9. PubMed ID: 7064851
    [Abstract] [Full Text] [Related]

  • 2. Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.
    Mehta J, Feldman RL, Marx JD, Kelly GA.
    Am J Med; 1983 Oct 17; 75(4A):32-9. PubMed ID: 6638039
    [Abstract] [Full Text] [Related]

  • 3. Effects of combined alpha- and beta-blockade by labetalol in patients with coronary artery disease.
    Condorelli M, Brevetti G, Chiariello M, Miceli D, Lavecchia G, Paudice G, Verrienti S.
    Br J Clin Pharmacol; 1982 Jun 17; 13(1 Suppl):101S-110S. PubMed ID: 7093092
    [Abstract] [Full Text] [Related]

  • 4. Circulatory responses to thiopentone and tracheal intubation in patients with coronary artery disease. Effects of pretreatment with labetalol.
    Fischler M, Dubois C, Brodaty D, Schlumberger S, Melchior JC, Guilmet D, Vourc'h G.
    Br J Anaesth; 1985 May 17; 57(5):493-6. PubMed ID: 3888239
    [Abstract] [Full Text] [Related]

  • 5. Systemic and coronary hemodynamic effects of combined oral alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress tests.
    Feldman RL, Prida XE, Hill JA.
    Clin Cardiol; 1988 Jun 17; 11(6):383-8. PubMed ID: 3396239
    [Abstract] [Full Text] [Related]

  • 6. Labetalol for the control of elevated blood pressure following coronary artery bypass grafting.
    Sladen RN, Klamerus KJ, Swafford MW, Prough DS, Mann HJ, Leslie JB, Goldberg JS, Levitsky S, Molina JE, Mills SA.
    J Cardiothorac Anesth; 1990 Apr 17; 4(2):210-21. PubMed ID: 2131869
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the alpha and beta blocking effects of intravenous labetalol on left ventricular function in coronary artery disease.
    Gagnon RM, Presant S, Morissette M.
    Can J Cardiol; 1985 Apr 17; 1(4):259-62. PubMed ID: 2996729
    [Abstract] [Full Text] [Related]

  • 8. Systemic and coronary hemodynamics of labetalol in normotensive patients with ischemic heart disease.
    Feldman RL, Prida XE, Lambert CR, Hill JA.
    Cardiovasc Drugs Ther; 1988 Sep 17; 2(3):355-61. PubMed ID: 3155428
    [Abstract] [Full Text] [Related]

  • 9. Combined alpha- and beta-blockade with labetalol in post-open heart surgery hypertension. Reversal of hemodynamic deterioration with glucagon.
    Meretoja OA, Allonen H, Arola M, Laaksonen VO.
    Chest; 1980 Dec 17; 78(6):810-5. PubMed ID: 7004797
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular effects of labetalol during halothane anaesthesia.
    Scott DB, Buckley FP, Drummond GB, Littlewoods DG, Macrae WR.
    Br J Clin Pharmacol; 1976 Aug 17; 3(4 Suppl 3):817-21. PubMed ID: 990159
    [Abstract] [Full Text] [Related]

  • 11. I.v. labetalol in the treatment of hypertension following coronary-artery surgery.
    Morel DR, Forster A, Suter PM.
    Br J Anaesth; 1982 Nov 17; 54(11):1191-6. PubMed ID: 7138722
    [Abstract] [Full Text] [Related]

  • 12. Systemic and coronary hemodynamic effects of combined alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress test responses.
    Prida XE, Hill JA, Feldman RL.
    Am J Cardiol; 1987 May 01; 59(12):1084-8. PubMed ID: 2883869
    [Abstract] [Full Text] [Related]

  • 13. [Intravenous labetalol in normotensive coronary patients. Effects on hemodynamics and myocardial metabolism].
    Ourbak P, Lardoux H, Pornin M, Bouziri S, Allal J, Duong TC, Sellier P, Maurice M.
    Arch Mal Coeur Vaiss; 1985 Jul 01; 78(7):1089-96. PubMed ID: 3929738
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
    Mehta J, Cohn JN.
    Circulation; 1977 Feb 01; 55(2):370-5. PubMed ID: 12880
    [Abstract] [Full Text] [Related]

  • 15. Hemodynamic effects of intravenous prostacyclin in stable angina pectoris.
    Firth BG, Winniford MD, Campbell WB, Hillis LD.
    Am J Cardiol; 1983 Sep 01; 52(5):439-43. PubMed ID: 6351580
    [Abstract] [Full Text] [Related]

  • 16. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
    Koch G.
    Br J Clin Pharmacol; 1976 Aug 01; 3(4 Suppl 3):725-8. PubMed ID: 10950
    [Abstract] [Full Text] [Related]

  • 17. Hemodynamic effects of labetalol in the dog. Comparative study in the anesthetized open-chest dog and in the conscious dog.
    Saito D, Abe Y, Tani H, Kusachi S, Takeda K, Hyodo T, Haraoka S, Nagashima H.
    Arzneimittelforschung; 1986 Aug 01; 36(1):88-91. PubMed ID: 2869764
    [Abstract] [Full Text] [Related]

  • 18. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P.
    Drugs; 1984 Aug 01; 28 Suppl 2():35-50. PubMed ID: 6151890
    [Abstract] [Full Text] [Related]

  • 19. Haemodynamic effects of long-term oral labetalol.
    Edwards RC, Raftery EB.
    Br J Clin Pharmacol; 1976 Aug 01; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [Abstract] [Full Text] [Related]

  • 20. The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels.
    Agabiti-Rosei E, Alicandri CL, Beschi M, Castellano M, Fariello R, Montini E, Muiesan ML, Romanelli G, Muiesan G.
    Br J Clin Pharmacol; 1982 Jun 01; 13(1 Suppl):87S-92S. PubMed ID: 7093104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.